CEO Salary & Executive Compensation
AbbVie ABBV
CEO: Robert Michael · Pharmaceuticals · 50,000 employees
Robert Michael, CEO of AbbVie (ABBV), earned $12.0M in total compensation in 2025. AbbVie receives a Pay-for-Performance grade of B (65/100), with a CEO-to-worker pay ratio of 120:1 and a say-on-pay shareholder approval of 87.2%. The company's 3-year total shareholder return is +2.5%.
How AbbVie CEO Pay Compares
Robert Michael's $12.0M total compensation is 0% below the Pharmaceuticals industry median of $12.0M. The 120:1 CEO-to-worker pay ratio is 4% lower than the industry average of 125:1.
Robert Michael, CEO of AbbVie (ABBV), received $12.0M in total reported compensation. The package mix typical at this scale: a small base salary, a larger stock-award component, and performance-tied incentives that vest over multiple years based on relative TSR or earnings benchmarks.
The CEO-to-median-worker pay ratio runs 120x. Lower ratios typically reflect companies with higher-paid workforces (financial services, technology, professional services) where the median worker pay denominator is itself substantial. Performance has been muted across the three-year window: 2.5% TSR, 6.1% revenue change. Stagnant performance combined with substantial CEO pay is the classic setup for proxy-advisor opposition on say-on-pay votes.
Shareholders supported the compensation package at 87% on the most recent say-on-pay vote. Solid support without overwhelming endorsement is the typical pattern for established public companies with conventional compensation programs. AbbVie operates in Pharmaceuticals with 50,000 employees and $54.3B in annual revenue, and currently carries a market capitalization of $310.0B. Pay comparisons across companies require controlling for these structural factors — a $20M package at a $10B-revenue tech company reads differently than the same package at a $1B-revenue industrial.
Source: SEC EDGAR — DEF 14A proxy statements for AbbVie (ABBV).
Compensation Breakdown
Robert Michael's $12.0M total compensation package for fiscal year 2025 includes $1.2M in base salary, $6.0M in stock awards, $1.4M in option awards, and $1.8M in bonus and non-equity incentives.
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2024 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2023 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
| 2022 | $1.2M | - | $6.0M | $1.4M | $1.8M | $1.3M | $12.0M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Peer CEO Compensation
Robert Michael, CEO of AbbVie (ABBV), earns $12.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
Frequently Asked Questions
Robert Michael, CEO of AbbVie (ABBV), earns $12.0M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
AbbVie has a Pay-for-Performance Score of B (65/100). The company's 3-year total shareholder return is +2.5%, and the say-on-pay shareholder vote passed with 87.2% approval.
The CEO-to-median-worker pay ratio at AbbVie is 120:1. The median worker at AbbVie earns $100K per year, while CEO Robert Michael earns $12.0M in total compensation.
AbbVie employs approximately 50,000 people. The company operates in the Pharmaceuticals industry within the Healthcare sector, generating $54.3B in annual revenue.